RxDoctor Payments Data

Dylan Pearson, MD

Critical Care Medicine · Greenwood Village, CONPI 1346531753

Payments from drug & device makers

What this record shows

14 manufacturers reported payments, led by Penumbra, Inc. at 38.7% of the total. 2025 is the largest year on record at $3,051, more than ten times the $94 reported in 2021.

$5,400in general payments, 2019–2025

Across 77 payments — averaging $70.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Penumbra, Inc.$2K
  • Pulmonx Corporation$1K
  • Getinge USA Sales, LLC$678
  • AstraZeneca$469
  • GSK$205
  • Abiomed$145
  • plus $504 from 8 others

What the payments were for

  • Travel & lodging$2,90854%
  • Food & beverage$2,49246%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,400 in reported general payments places this provider in the 85th percentile of 141 critical care medicine providers in Colorado.

See all critical care medicine providers in Colorado

Medicare billing

Part B allowed, 2024
$77,221
Medicare patients
266
Services billed
543

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter55$54,319
Breztri AerosphereBudesonide/Glycopyr/Formoterol18$18,855
EliquisApixaban15$12,681
Stiolto RespimatTiotropium Br/Olodaterol Hcl20$9,629
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr14$6,654
SymbicortBudesonide/Formoterol Fumarate12$3,808
Albuterol Sulfate HfaAlbuterol Sulfate57$1,662
Azithromycin11$16

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$205$60,97369 claims
AstraZenecaBreztri Aerosphere, Symbicort$469$22,66330 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 141 critical care medicine providers in Colorado.

Other critical care medicine in Greenwood Village

See the full list for Colorado

Where these figures come from

Is this you, or does something look wrong? →